Seeing Is Believing
Currently out of the existing stock ratings of Keyur Parekh, 8 are a BUY (72.73%), 3 are a HOLD (27.27%).
Analyst Keyur Parekh works with a stock forecast success ratio of 33.33% fulfilled within 242.5 days on average.
Keyur Parekh’s has documented 19 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on GSK, GlaxoSmithKline PLC ADR at 24-Feb-2023.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVS (NOVARTIS AG ADR) at 11/19/2018. The price target of $77.42 was fulfilled within 211 days with a profit of $12.9 (19.99%) receiving and performance score of 0.95.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
80
$11.74 (17.20%)
83
1 months 16 days ago
0/3 (0%)
$19.52 (32.28%)
Hold
1 months 20 days ago
0/11 (0%)
$82.61 (131.40%)
Buy
85
$16.74 (24.52%)
2 months 5 days ago
0/11 (0%)
$19.26 (29.30%)
Hold
70
$1.74 (2.55%)
2 months 25 days ago
4/5 (80%)
$2.71 (4.03%)
253
Buy
142.74
8 months 16 days ago
0/6 (0%)
$75.62 (112.66%)
What Year was the first public recommendation made by Keyur Parekh?